Australia Medical Devices Market Outlook to 2030
By Device Category (Diagnostic Imaging Systems, Therapeutic & Surgical Devices, Implantable Devices, Consumables & Disposables, In-Vitro Diagnostics, Digital Health Devices & SaMD), By Therapeutic Area (Cardiology, Orthopedics & Spine, ENT & Audiology
Report Overview
Report Code
TDR0224
Coverage
Asia
Published
August 2025
Pages
80
Flexible Purchase Options
Select and purchase only the chapters you need for your strategic decisions
On This Page
Report Overview
Executive summary will be available soon.
Report Coverage
Verified Market Sizing
Multi-layer forecasting with historical data and 5–10 year outlook
Deep-Dive Segmentation
Cross-sectional analysis by product type, end user, application and region
Competitive Benchmarking & Positioning
Market share, operating model, pricing and competition matrices
Actionable Insights & Risk Assessment
High-growth white spaces, underserved segments, technology disruptions and demand inflection points
Review Methodology & Data Structure
Preview report structure, data sources and research framework
Executive Summary
Explore Flexible Purchase Options or Have Limited Budget?
Pay only for relevant chapters • Customizable report sections
Table of Contents
Choose individual sections to purchase. Mix and match as you like.
[OEMs, distributors, TGA, MSAC, PHI funds, hospital procurement agencies, clinical societies, research institutes, MTPConnect]
4.1. Delivery Model Analysis for Medical Devices-Direct Sales, Distributor-Led, Managed Service/PPU, E-commerce, Consignment [margins, preference, strengths, weaknesses]
4.2. Revenue Streams for Australia Medical Devices Market [capital sales, consumables, service contracts, software subscriptions, leasing/rental, managed equipment services]
4.3. Business Model Canvas for Australia Medical Devices Market [key partners, activities, value propositions, customer segments, cost structure, revenue streams]
5.1. Local Manufacturers vs. Import-Dependent Supply [share, capabilities, resilience]
5.2. Investment Model in Australia Medical Devices Market [public capex, private equity, venture, state grants, MRFF funding]
5.3. Comparative Analysis of Public vs. Private Hospital Procurement Processes [tender cycles, evaluation criteria, clinical trials for adoption]
5.4. Device Budget Allocation by Hospital Size and Type [public tertiary, private groups, day surgery centers]
[Regulatory stability, reimbursement environment, competitive intensity, technology readiness, demand growth, capital availability]
[installed base age, unmet clinical needs, waiting list backlogs, regional disparities in access]
8.1. Revenues, Historical and Current (AUD Bn) [2019-2024]
9.1. By Market Structure (Domestic Manufacture vs. Imports), 2023-2024P
9.2. By Device Category (Diagnostic Imaging, Therapeutic & Surgical, Implantables, Consumables, IVD, Digital Health/SaMD), 2023-2024P
9.3. By Therapeutic Area (Cardiology, Orthopedics, ENT/Audiology, Respiratory & Sleep, Neurology, General Surgery, Wound Care), 2023-2024P
9.3.1. By Type of Cardiology Devices (Stents, Pacemakers, TAVR, Diagnostics), 2023-2024P
9.3.2. By Type of Orthopedic Devices (Joint Implants, Trauma, Spine, Sports Medicine), 2023-2024P
9.3.3. By Type of IVD (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Point-of-Care), 2023-2024P
9.3.4. By Type of Digital Health Devices (Wearables, Remote Monitoring, Diagnostic AI, Telehealth Peripherals), 2023-2024P
9.4. By End User (Public Hospitals, Private Hospitals, Day Surgery Centers, Diagnostic Imaging Centers, Pathology Labs, Primary Care/GP Clinics, Home-Care), 2023-2024P
9.5. By Risk Class (Class I-III, AIMD, IVD classes), 2023-2024P
9.6. By Distribution Channel (Direct Sales, National Distributors, Specialty Distributors, E-commerce, Group Purchasing), 2023-2024P
9.7. By Care Setting (Acute Inpatient, Ambulatory, Community, Home-Based, Virtual Care), 2023-2024P
9.8. By Region (NSW, VIC, QLD, WA, SA, TAS, ACT, NT), 2023-2024P
10.1. Hospital and Clinic Landscape & Cohort Analysis [bed capacity, procedural volumes, technology adoption tiers]
10.2. Device Adoption Needs and Decision-Making Process [procurement committees, clinical evidence review, cost-benefit evaluation]
10.3. Clinical & Economic Effectiveness and ROI Analysis [patient outcomes, hospital throughput, cost offsets]
10.4. Gap Analysis Framework [technology penetration vs. clinical demand, region-specific needs]
11.1. Trends and Developments [miniaturization, robotics, AI in diagnostics, UDI rollout, ESG commitments]
11.2. Growth Drivers [ageing population, chronic disease burden, technological innovation, public-private partnerships]
11.3. SWOT Analysis [strengths in innovation, weaknesses in local manufacturing, opportunities in home-care, threats from regulatory changes]
11.4. Issues and Challenges [TGA compliance costs, procurement price pressures, workforce shortages]
11.5. Government Regulations [TGA Essential Principles, ARTG registration, Prostheses List reforms, MSAC HTA processes]
12.1. Market Size and Future Potential for Digital Medical Devices in Australia, 2019-2030
12.2. Business Model and Revenue Streams [device + SaaS bundles, subscription monitoring, pay-per-use]
12.3. Delivery Models and Key Application Areas [home monitoring, telehealth peripherals, AI-enabled diagnostics]
12.4. Cross Comparison of Leading Digital Device Companies [company overview, local incorporation, revenues, installed base, product portfolio, funding, pricing models, regulatory approvals]
15.1. Market Share of Key Players in Australia Medical Devices Market Basis Revenues, 2024
15.2. Benchmark of Key Competitors [company overview, USP, business strategies, product portfolio, ARTG listings, Prostheses List items, revenues, pricing by category, technology used, best-selling devices, major clients, strategic tie-ups, marketing strategy, recent developments]
15.3. Operating Model Analysis Framework [direct vs. distributor-led, consignment levels, service coverage]
15.4. Gartner Magic Quadrant Equivalent [technology leadership vs. execution capability]
15.5. Bowmans Strategic Clock for Competitive Advantage
16.1. Revenues, 2025-2030
17.1. By Market Structure (Domestic Manufacture vs. Imports), 2025-2030
17.2. By Device Category, 2025-2030
17.3. By Therapeutic Area, 2025-2030
17.3.1. By Type of Cardiology Devices, 2025-2030
17.3.2. By Type of Orthopedic Devices, 2025-2030
17.3.3. By Type of IVD, 2025-2030
17.3.4. By Type of Digital Health Devices, 2025-2030
17.4. By End User, 2025-2030
17.5. By Risk Class, 2025-2030
17.6. By Distribution Channel, 2025-2030
17.7. By Care Setting, 2025-2030
17.8. By Region, 2025-2030
Discuss a Customized Research Scope
Custom research scope • Tailored insights • Industry expertise
Research Methodology
Step 1: Ecosystem Creation
Map the ecosystem and identify all the demand-side and supply-side entities for the Australia Medical Devices Market. On the demand side, this includes public hospitals, private hospital groups, day surgery centers, diagnostic imaging networks, pathology labs, home-care providers, and government procurement bodies (e.g., HealthShare NSW, Health Purchasing Victoria). On the supply side, this covers OEMs, local manufacturers, contract manufacturers, distributors, regulatory bodies (TGA, MSAC), and logistics partners. Based on this mapping, we shortlist 5–6 leading device suppliers in Australia using parameters such as ARTG listings, installed base, state procurement contracts, financial performance, and geographic service coverage. Sourcing leverages government procurement records, OEM/distributor disclosures, annual reports, and trusted medical industry publications to compile market-level intelligence.
Step 2: Desk Research
An exhaustive secondary research process is carried out using TGA databases, hospital procurement portals, industry associations (e.g., MTAA), and proprietary medtech market databases. This enables a detailed analysis of industry revenues, device category penetration, procurement cycles, reimbursement structures, and regulatory timelines. Company-level analysis is conducted through examination of press releases, annual reports, ARTG records, and device recall/alert notices. Special focus is given to metrics such as installed base per modality, service network size, product portfolio breadth, and local manufacturing footprint to establish a strong foundation for competitive and market structure insights.
Step 3: Primary Research
We conduct structured interviews with C-level executives, product managers, and regulatory affairs leads from OEMs, distributors, and service providers active in Australia. Hospital procurement managers, biomedical engineers, and clinicians are also interviewed to validate buying criteria, operational challenges, and device performance perceptions. This primary work validates secondary data, clarifies regulatory compliance impacts, and provides bottom-up revenue attribution by player and category. As part of validation, our team also engages in disguised client inquiries with device suppliers to confirm tender pricing structures, delivery SLAs, warranty/servicing agreements, and device configuration options—cross-checking all such findings with procurement records and ARTG documentation.
Step 4: Sanity Check
A dual bottom-up and top-down sizing exercise is conducted. Bottom-up estimates aggregate category-level revenues from player-level data, procedure volumes, and device utilisation rates. Top-down validation references public health expenditure, capital investment trends, and import/export values by HS codes from ABS trade statistics. Any gaps are reconciled through further interviews or targeted secondary searches, ensuring the final market model is both statistically robust and aligned with real-world operational and regulatory conditions in the Australia Medical Devices Market.
See What's Inside the Report
Get a preview of key findings, methodology and report coverage
Frequently Asked Questions
01 What is the potential for the Australia Medical Devices Market?
The Australia Medical Devices Market shows strong upside driven by an ageing population, high procedure volumes in public and private hospitals, and rapid adoption of minimally invasive and digitally connected technologies. Robust reimbursement frameworks (MBS/Prostheses List), active health infrastructure investment, and a clinically engaged ecosystem of registries and key opinion leaders support steady device utilisation. Australia also hosts globally respected medtech innovators—particularly in hearing, respiratory, infection prevention, and imaging—which amplifies export potential across Asia–Pacific. Together, these factors position the market for durable, innovation-led growth across implantables, diagnostics, surgical technologies, and home-based care.
02 Who are the Key Players in the Australia Medical Devices Market?
The market features a blend of global leaders and home-grown champions with deep clinical and service footprints. Key participants include Medtronic, Johnson & Johnson MedTech (Ethicon/DePuy Synthes), Abbott, Boston Scientific, Stryker, Becton Dickinson (BD), Siemens Healthineers, GE HealthCare, and Philips. Australia-based innovators such as Cochlear, ResMed, and Nanosonics anchor world-class capabilities in hearing implants, sleep/respiratory care, and infection prevention. Other notable players include Fisher & Paykel Healthcare, Hologic, and Olympus, collectively shaping competitive dynamics across operating theatres, catheter labs, imaging suites, pathology, and out-of-hospital care.
03 What are the Growth Drivers for the Australia Medical Devices Market?
Growth is propelled by sustained surgical and interventional workloads, rising chronic disease burden (cardiovascular, oncology, respiratory), and an accelerated shift toward minimally invasive and ambulatory care. Hospitals are modernising imaging and theatre ecosystems, while home-based and virtual care pathways expand demand for portable monitoring, connected devices, and diagnostics. National procurement and reimbursement frameworks reward clinically proven innovations, and strong university–hospital–industry linkages foster clinical evidence generation. Local manufacturing incentives and supply-chain resilience programs add momentum, supporting both domestic adoption and export-oriented production across priority therapeutic areas.
04 What are the Challenges in the Australia Medical Devices Market?
Manufacturers and sponsors face rigorous regulatory and evidence requirements under TGA/ARTG pathways, alongside evolving HTA expectations for clinical and economic value. Centralised, high-volume tenders in public systems compress pricing and raise service-level commitments, while Prostheses List reforms require continual portfolio and coding optimisation for private hospital usage. Geographic dispersion increases logistics, service, and loan-kit complexity outside major metros. Workforce constraints in theatres, sterilisation services, and biomedical engineering can limit throughput and adoption speed, placing a premium on training, uptime guarantees, and integrated service models.
License Options
PDF + Excel
Complete report package
$4,000
Excel Only
Data and analytics
$2,500
Custom Sections
Starts from $100
$0